Nature CommunicationsGenetic & Genomic MedicinePeer-reviewed journal article
Unveiling the crucial neuronal role of the proteasomal ATPase subunit gene PSMC5 in neurodevelopmental proteasomopathies
Sébastien KüryiD, Janelle E. StantoniD, Geeske M. van WoerdeniD, Amélie Bosc-RosatiiD, Tzung‐Chien HsiehiD, Lise BrayiD, Marielle OloudéiD, Cory Scott RosenfeltiD, Marie‐Pier Scott‐BoyeriD, Victoria MostiD, Tianyun WangiD, Jonas Johannes Papendorf, Charlotte de KoninkiD, Wallid DebiD, Virginie VignardiD, Maja Studencka‐TurskiiD, Thomas BesnardiD, Anna Marta Hajdukowicz, Franziska Gisela ThieliD, Sophie WolfgrammiD, Laëtitia FlorenceauiD, Silvestre CuinatiD, Sylvain Marsac, Yann VerrèsiD, Audrey DangoumauiD, , Marta Codina‐SolàiD
Abstract
Neurodevelopmental proteasomopathies represent a distinctive category of neurodevelopmental disorders (NDD) characterized by genetic variations within the 26S proteasome, a protein complex governing eukaryotic cellular protein homeostasis. In our comprehensive study, we identified 23 unique variants in PSMC5, which encodes the AAA-ATPase proteasome subunit PSMC5/Rpt6, causing syndromic NDD in 38 unrelated individuals. Overexpression of PSMC5 variants altered human hippocampal neuron morphology, while PSMC5 knockdown led to impaired reversal learning in flies and loss of excitatory synapses in rat hippocampal neurons. PSMC5 loss-of-function resulted in abnormal protein aggregation, profoundly impacting innate immune signaling, mitophagy rates, and lipid metabolism in affected individuals. Importantly, targeting key components of the integrated stress response, such as PKR and GCN2 kinases, ameliorated immune dysregulations in cells from affected individuals. These findings significantly advance our understanding of the molecular mechanisms underlying neurodevelopmental proteasomopathies, provide links to research in neurodegenerative diseases, and open up potential therapeutic avenues.
- organism: human
- organism: rat
- organism: Drosophila
- assay: proteomics
- assay: electronic health records
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 3
- FWCI
- 0.90
- Field percentile
- top 27%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Proteasome subunit PSMC3 variants cause neurosensory syndrome combining deafness and cataract due to proteotoxic stress
Ariane Kröll‐Hermi, Frédéric Ebstein, … Hélène Dollfus·EMBO Molecular MedicinePeer-reviewed·Jun 5, 2020
- Quantitative proteomics and phosphoproteomics of PPP2R5D variants reveal deregulation of RPS6 phosphorylation through converging signaling cascades
K. A. Smolen, C. M. Papke, … A. N. Kettenbach·bioRxiv·Mar 27, 2023
- Loss-of-function mutations in the dystonia gene THAP1 impair proteasome function by inhibiting PSMB5 expression
Dylan E. Ramage, Drew W. Grant, Richard T. Timms·Nature CommunicationsPeer-reviewed·Feb 10, 2025
- Cortical Organoid Model of PPP2R5D Genetic Intellectual Disability Models Disease Severity Phenotype
Yuxin Du, Mandeep Singh, … Kyle D. Fink·bioRxiv·May 27, 2026
- Impaired proteasome induces mitochondrial DNA release to activate the cGAS-STING signaling pathway and cause necroptosis in mouse brain
Abena Dwamena, Yasin Asadi, … Hongmin Wang·bioRxiv·Nov 13, 2024
- Proteomics and phosphoproteomics profiling in glutamatergic neurons and microglia in an iPSC model of Jansen de Vries Syndrome
Jennifer T. Aguilan, Erika Pedrosa, … Herbert M. Lachman·bioRxiv·Jul 8, 2023